Results 91 to 100 of about 19,462,706 (409)
Contested futures: envisioning “Personalized,” “Stratified,” and “Precision” medicine [PDF]
Sonja Erikainen, Sarah Chan
openalex +1 more source
Adenoviruses in medicine: innocuous pathogen, predator, or partner
Katelyn M. MacNeil +5 more
openalex +1 more source
The next generation of evidence-based medicine
V. Subbiah
semanticscholar +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy +9 more
wiley +1 more source
Pharmacogenomics: A road ahead for precision medicine in psychiatry
Antonio F. Pardiñas +2 more
openalex +2 more sources
Emerging role of ARHGAP29 in melanoma cell phenotype switching
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster +3 more
wiley +1 more source
Medical Student Summer Externship Program: Increasing the Number Matching in Family Practice [PDF]
: Background and Objectives. The number of US allopathic medical school graduates choosing a residency in family medicine has fallen from 13.4% in 1999 to 10.5% in 2002.
Cronau, MD, Holly +1 more
core
Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information [PDF]
Michelle Koo, Ines Krass, Parisa Aslani
openalex +1 more source
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source

